By: Dividend Sensei
Hyper-growth stocks can help many people achieve their rich retirement goals. That’s assuming you focus on safety and quality first, and prudent valuation and risk management always.
In today’s 37% overvalued market, finding the right hyper-growth blue-chips is harder, but still possible, if you know where to look.
One of these companies is one of the world’s fastest-growing pharma SWANs, with a cancer blockbuster packed pipeline that analysts expect to deliver 20% long-term growth.
This blue-chip is 13% undervalued and offering 27% CAGR consensus total return potential over the next three years. Analysts think it could outperform the S&P 500 by almost 100% by 2023.
This other blue-chip is the retail king of China and planning to quadruple its growth spending over the next five years. This speculative hyper-growth blue-chip is expected to grow 40% CAGR over time, making it one of the fastest-growing blue-chips on Wall Street.